Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL; water for injections

Fáanlegur frá:

Hospira Australia Pty Ltd

INN (Alþjóðlegt nafn):

Gemcitabine hydrochloride,water for injections

Lyfjaform:

Injection, solution

Samsetning:

Excipient Ingredients: sodium hydroxide; hydrochloric acid

Stjórnsýsluleið:

Intravenous Infusion

Einingar í pakka:

1 x 5.26 mL pack

Tegund:

Medicine Listed (Export Only)

Gerð lyfseðils:

(S1) This Schedule is intentionally blank

Ábendingar:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Vörulýsing:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Leyfisstaða:

Licence status A

Leyfisdagur:

2011-11-04